News and commentary on IP issues
Recent News

UK Supreme Court invalidates transgenic mouse patents for insufficiency

Regeneron Pharmaceuticals' European patent EP 1360287 and its divisional EP 2264163 relate to methods of producing transgenic mice able to produce antibodies having human sequences, and the mice produced thereby. These patents covered the idea of producing mice having mixed human-murine gene sequences that could be subsequently modified t...

Continue reading

The European patent office has announced here that until 31 August 2020, no surcharge is payable for late paid renewal fees.  This provision applies to EPO renewal fees having a deadline (without extension) between 15 March 2020 and 30 August 2020.  Cases falling into this provision, will be deemed validly paid if the renew...